Hosted on MSN8mon
Moderna wins a battle in vaccine patent dispute with Pfizer-BioNTechModerna said Friday that the European Patent ... rival COVID-19 vaccines. Cambridge-based Moderna has been fighting Pfizer and BioNTech in the courts over the partners’ COVID shot, called ...
10mon
MyChesCo on MSNArbutus Biopharma Wins Key Ruling in Patent Suit Against Moderna Over COVID-19 Vaccine TechnologyWARMINSTER, PA — Arbutus Biopharma Corporation recently announced a favorable outcome in its ongoing patent ... of the case, ...
The European Patent Office has said it has invalidated a patent held by Moderna on mRNA-based COVID-19 vaccines, the latest development in an increasingly acrimonious dispute between the company ...
Pfizer and partner BioNTech have launched a countersuit against Moderna in a patent ... and COVID-19 vaccines entered regular commercial trade with producers competing for the booster shot market ...
Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to ...
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe May 17, 2024 Germany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during the pandemic ...
Demand for its COVID vaccine has been waning since the pandemic, while adoption of its RSV shot - its second approved product- has been slower than expected, forcing Moderna to cut costs.
Moderna (NASDAQ:MRNA), Novavax (NASDAQ:NVAX), and other vaccine developers extended recent gains on Tuesday as investors reacted to rising flu and COVID-19 cases in the U.S. following the latest ...
The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase III trial that will test out a vaccine against norovirus, a frequent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results